Common and Idiosyncratic Patterns of Cytokine Gene Expression by Epstein-Barr Virus Transformed Human B Cell Lines

1997 ◽  
Vol 10 (4) ◽  
pp. 183-195 ◽  
Author(s):  
ROSEMARY ROCHFORD ◽  
MARTIN J. CANNON ◽  
REBECCA E. SABBE ◽  
KALYANI ADUSUMILLI ◽  
GASTON PICCHIO ◽  
...  
1998 ◽  
Vol 24 (4) ◽  
pp. 257-262 ◽  
Author(s):  
Elke Schäffner ◽  
Oliver Opitz ◽  
Klaus Pietsch ◽  
Georg Bauer ◽  
Stefan Ehlers ◽  
...  

2018 ◽  
Vol 121 (1) ◽  
Author(s):  
Liang Wei Wang ◽  
Stephen J. Trudeau ◽  
Chong Wang ◽  
Catherine Gerdt ◽  
Sizun Jiang ◽  
...  

1982 ◽  
Vol 156 (3) ◽  
pp. 930-935 ◽  
Author(s):  
N Chiorazzi ◽  
R L Wasserman ◽  
H G Kunkel

HGPRTase-deficient EBV-transformed B cell lines were shown to be effective fusion partners with mitogen-activated human B cells for the construction of Ig-producing human B cell hybridomas. In a series of experiments using these lines and B cells from several tissue sources, approximatley 20% of the cultures plated were consistently positive for growth after hypoxanthine-aminopterin-thymidine selection and approximatley 30% of these synthesized significant new Ig. A marked increase in Ig secretion was observed after hybridization, which was due to new Ig; Ig from the parental lime was shown to disappear in several instances. Special analyses were carried out on a human hybridoma secreting antibody specific for tetanus toxoid and tetanus toxin and stable subclones were derived. These studies suggest that EBV-transformed lines will prove useful in human hybridization studies, thus making a large library of B cell lines available for the generation of human monoclonal antibodies.


2021 ◽  
Author(s):  
Fang Lu ◽  
Kayla A. Martin ◽  
Samantha S. Soldan ◽  
Andrew V. Kossenkov ◽  
Priyankara Wickramasinghe ◽  
...  

Epstein-Barr virus (EBV) is a human γ-herpesvirus that is causally associated with various lymphomas and carcinomas. Although EBV is not typically associated with multiple myeloma (MM), it can be found in some B-cell lines derived from multiple myeloma patients. Here, we analyzed two EBV+ MM-patient derived cell lines IM9 and ARH77 and found defective viral genomes and atypical viral gene expression patterns. We performed RNA-seq transcriptomics to characterize the viral and cellular properties of the two EBV+ cell lines compared to canonical MM cell line 8226. Principal component analyses indicated that IM9 and ARH77 clustered together and distinct from 8226. ImmGen analysis designate these cells as stem-cell and bone marrow derived. IM9 and ARH77 displayed atypical viral gene expression, including a leaky lytic cycle gene expression with absence of lytic DNA amplification. Genome sequencing revealed that EBV genomes in ARH77 contain large deletions, while IM9 has copy number losses in multiple EBV loci. Both IM9 and ARH77 show EBV genome heterogeneity suggestive of cell harboring multiple and variant viral genomes. We identified atypical high-level expression for lytic genes BLRF1 and BLRF2. We demonstrate that shRNA depletion of BLRF2 alters viral and host gene expression, including a reduction in lytic gene activation and DNA amplification. These findings demonstrate that aberrant viral genomes and lytic gene expression persist in rare B-cells derived from MM tumors, and suggest that EBV may contribute to etiology of MM. Importance Epstein-Barr Virus (EBV) is an oncogenic herpesvirus but its mechanisms of oncogenesis are not fully understood. A role for EBV in multiple myeloma has not yet been established. We analyzed EBV positive B-cell lines derived from multiple myeloma patients and found these cells harbor defective viral genomes with aberrant viral gene expression patterns and cell gene signatures for bone marrow derived lymphoid stem cells. These findings suggest that aberrant EBV latent infection may contribute to the etiology of multiple myeloma.


1984 ◽  
Vol 65 (10) ◽  
pp. 1781-1789 ◽  
Author(s):  
Y. Koyanagi ◽  
N. Yamamoto ◽  
N. Kobayashi ◽  
K. Hirai ◽  
H. Konishi ◽  
...  

1993 ◽  
Vol 177 (2) ◽  
pp. 295-304 ◽  
Author(s):  
N Burdin ◽  
C Péronne ◽  
J Banchereau ◽  
F Rousset

Interleukin 10 (IL-10) is a pleiotropic factor that enhances proliferation of activated human B lymphocytes and induces them to secrete high amounts of immunoglobulins. Here we show that several human B cell lines were able to constitutively secrete human (h)IL-10. Whereas none of the pre-B nor the plasmocytic cell lines tested produced hIL-10, 25 of the 36 tested mature B cell lines (lymphoblastoid and Burkitt lymphoma cell lines) secreted hIL-10. Moreover, 24 of these 25 hIL-10-producing B cell lines contained the Epstein-Barr virus (EBV) genome, suggesting a relationship between hIL-10 production by human B cell lines and EBV expression. Accordingly, whereas polyclonal activation via triggering of surface immunoglobulins or CD40 antigen induced highly purified normal human B lymphocytes to produce only low (0.3-0.4 ng/ml) but significant amounts of hIL-10, EBV infection induced them to secrete high amounts of hIL-10 (4-9 ng/ml). Furthermore, addition of exogenous hIL-10, simultaneously to EBV infection, potentiated cell proliferation, whereas a blocking anti-IL-10 antiserum inhibited it. Thus, hIL-10 produced by infected human B lymphocytes appears to be involved in the mechanisms of EBV-induced B cell proliferation.


2001 ◽  
Vol 183 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Shouichi Ohga ◽  
Akihiko Nomura ◽  
Hidetoshi Takada ◽  
Kenji Ihara ◽  
Kiyoshi Kawakami ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document